Global Information
회사소개 | 문의

양압호흡기 : 의료기기 파이프라인 평가

Positive Airway Pressure Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 02월 상품 코드 606448
페이지 정보 영문 149 Pages
가격
US $ 2,500 ₩ 2,848,500 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,697,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,545,500 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


양압호흡기 : 의료기기 파이프라인 평가 Positive Airway Pressure Devices - Medical Devices Pipeline Assessment, 2018
발행일 : 2018년 02월 페이지 정보 : 영문 149 Pages

양압호흡기 파이프라인 제품에 대해 조사했으며, 제품 개발·임상시험의 전체적 진행 상황, 기업·제품별 상세 동향, 최근 개발·자본거래 동향 등을 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 양압호흡기 개요

제3장 개발중인 파이프라인 제품

  • 양압호흡기 : 개발 단계별
  • 양압호흡기 : 부문별
  • 양압호흡기 : 지역/국가별
  • 양압호흡기 : 승인 기관별
  • 양압호흡기 : 추정 승인 기간
  • 양압호흡기 : 현재 진행중인 임상시험

제4장 개발중인 파이프라인 제품 : 기업별

  • 양압호흡기 기업 : 개발 단계별 파이프라인 제품
  • 양압호흡기 : 개발 단계별 파이프라인 제품

제5장 양압호흡기 : 기업 및 제품 개요

  • Airing LLC
    • 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Beijing Dehaier Medical Technology Co Ltd
  • Cleveland Medical Devices Inc
  • Fisher & Paykel Healthcare Corporation Limited
  • HCi Viocare Technologies Ltd
  • KeepMED Ltd
  • Koninklijke Philips N.V.
  • Metamason Inc
  • RespiNova Ltd
  • Rhinomed Ltd
  • Sleep Secure LLC
  • University of Cincinnati
  • Vincent Medical Holdings Ltd

제6장 양압호흡기 시장 - 최근 동향

제7장 부록

  • 조사 방법
  • GlobalData 소개
  • 연락처
  • 면책사항

도표 리스트

KSA 18.03.08

List of Tables

  • Table 1: Positive Airway Pressure Devices - Pipeline Products by Stage of Development 8
  • Table 2: Positive Airway Pressure Devices - Pipeline Products by Segment 9
  • Table 3: Positive Airway Pressure Devices - Pipeline Products by Territory 10
  • Table 4: Positive Airway Pressure Devices - Pipeline Products by Regulatory Path 11
  • Table 5: Positive Airway Pressure Devices - Pipeline Products by Estimated Approval Date 12
  • Table 6: Positive Airway Pressure Devices - Ongoing Clinical Trials 13
  • Table 7: Positive Airway Pressure Devices Companies - Pipeline Products by Stage of Development 14
  • Table 8: Positive Airway Pressure Devices - Pipeline Products by Stage of Development 15
  • Table 9: Airing LLC Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 10: Airing Device - Product Status 16
  • Table 11: Airing Device - Product Description 16
  • Table 12: Beijing Dehaier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 13: DHR-A8 Auto Continuous Positive Airway Pressure Device - Product Status 17
  • Table 14: DHR-A8 Auto Continuous Positive Airway Pressure Device - Product Description 17
  • Table 15: Second Generation CPAP Device - Product Status 18
  • Table 16: Second Generation CPAP Device - Product Description 18
  • Table 17: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 18: Auto-Titrating CPAP - Product Status 19
  • Table 19: Auto-Titrating CPAP - Product Description 19
  • Table 20: Fisher & Paykel Healthcare Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 21: SleepStyle CPAP Device - Product Status 20
  • Table 22: SleepStyle CPAP Device - Product Description 20
  • Table 23: Fisher & Paykel Healthcare Corporation Limited - Ongoing Clinical Trials Overview 21
  • Table 24: SleepStyle CPAP Device - Randomized Trial Comparing CPAP Machines with Reusable Versus Disposable Circuits 22
  • Table 25: HCi Viocare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 26: Sleep apnea device (BiPAP) - Product Status 23
  • Table 27: Sleep apnea device (BiPAP) - Product Description 23
  • Table 28: KeepMED Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 29: KeePAP - Product Status 24
  • Table 30: KeePAP - Product Description 24
  • Table 31: Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 32: DreamStation Go - Product Status 25
  • Table 33: DreamStation Go - Product Description 25
  • Table 34: Metamason Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 35: Respere Secure - Product Status 26
  • Table 36: Respere Secure - Product Description 26
  • Table 37: RespiNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 38: PulseHaler - Product Status 27
  • Table 39: PulseHaler - Product Description 27
  • Table 40: Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 41: Intranasal Positive Expiratory Airway Pressure (INPEAP) Device - Product Status 28
  • Table 42: Intranasal Positive Expiratory Airway Pressure (INPEAP) Device - Product Description 28
  • Table 43: Rhinomed Ltd - Ongoing Clinical Trials Overview 29
  • Table 44: Intranasal Positive Expiratory Airway Pressure (INPEAP) Device - Pilot Study of Novel Intranasal Positive Expiratory Airway Pressure Device to Treat Moderate Obstructive Sleep Apnea (OSA) 30
  • Table 45: Sleep Secure LLC Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 46: Sleep Secure Device - Product Status 31
  • Table 47: Sleep Secure Device - Product Description 31
  • Table 48: University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 49: Acoustic Jet Device - Product Status 32
  • Table 50: Acoustic Jet Device - Product Description 32
  • Table 51: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 52: Infant Bubble CPAP System - Product Status 33
  • Table 53: Infant Bubble CPAP System - Product Description 33
  • Table 54: Glossary 148

GlobalData's Medical Devices sector report, "Positive Airway Pressure Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Positive Airway Pressure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positive Airway Pressure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positive Airway Pressure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positive Airway Pressure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positive Airway Pressure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Positive Airway Pressure Devices Overview 7

3 Products under Development 8

  • 3.1 Positive Airway Pressure Devices - Pipeline Products by Stage of Development 8
  • 3.2 Positive Airway Pressure Devices - Pipeline Products by Segment 9
  • 3.3 Positive Airway Pressure Devices - Pipeline Products by Territory 10
  • 3.4 Positive Airway Pressure Devices - Pipeline Products by Regulatory Path 11
  • 3.5 Positive Airway Pressure Devices - Pipeline Products by Estimated Approval Date 12
  • 3.6 Positive Airway Pressure Devices - Ongoing Clinical Trials 13

4 Positive Airway Pressure Devices - Pipeline Products under Development by Companies 14

  • 4.1 Positive Airway Pressure Devices Companies - Pipeline Products by Stage of Development 14
  • 4.2 Positive Airway Pressure Devices - Pipeline Products by Stage of Development 15

5 Positive Airway Pressure Devices Companies and Product Overview 16

  • 5.1 Airing LLC Company Overview 16
    • 5.1.1 Airing LLC Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Beijing Dehaier Medical Technology Co Ltd Company Overview 17
    • 5.2.1 Beijing Dehaier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Cleveland Medical Devices Inc Company Overview 19
    • 5.3.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.4 Fisher & Paykel Healthcare Corporation Limited Company Overview 20
    • 5.4.1 Fisher & Paykel Healthcare Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.5 HCi Viocare Technologies Ltd Company Overview 23
    • 5.5.1 HCi Viocare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 KeepMED Ltd Company Overview 24
    • 5.6.1 KeepMED Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 Koninklijke Philips N.V. Company Overview 25
    • 5.7.1 Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Metamason Inc Company Overview 26
    • 5.8.1 Metamason Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 RespiNova Ltd Company Overview 27
    • 5.9.1 RespiNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 Rhinomed Ltd Company Overview 28
    • 5.10.1 Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 Sleep Secure LLC Company Overview 31
    • 5.11.1 Sleep Secure LLC Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.12 University of Cincinnati Company Overview 32
    • 5.12.1 University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Vincent Medical Holdings Ltd Company Overview 33
    • 5.13.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

6 Positive Airway Pressure Devices- Recent Developments 34

  • 6.1 Jan 31, 2018: Rhinomed: Business Update - December Quarter Cashflow 34
  • 6.2 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 35
  • 6.3 Jan 22, 2018: ResMed Reports Second Quarter of Fiscal Year 2018 Financial Results 36
  • 6.4 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 38
  • 6.5 Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice 38
  • 6.6 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 38
  • 6.7 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 39
  • 6.8 Nov 21, 2017: Strong Half Year Result from Fisher & Paykel Healthcare: Record Net Profit of NZ$81.3 Million 40
  • 6.9 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 41
  • 6.10 Nov 17, 2017: ResMed Elects Karen Drexler to Its Board of Directors 44
  • 6.11 Nov 16, 2017: Study shows therapy improves quality of life in people who have sleep apnea 44
  • 6.12 Nov 08, 2017: Significant cost reduction in COPD care with simple, drug-free device 45
  • 6.13 Nov 08, 2017: Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser 47
  • 6.14 Nov 08, 2017: Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK 48
  • 6.15 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 49
  • 6.16 Nov 07, 2017: Electromed Announces Fiscal 2018 First Quarter Financial Results 50
  • 6.17 Nov 06, 2017: ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP 51
  • 6.18 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018 52
  • 6.19 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan 53
  • 6.20 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 56
  • 6.21 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 57
  • 6.22 Oct 30, 2017: GSK opens new regional headquarters for Asia in Singapore 59
  • 6.23 Oct 26, 2017: ResMed Announces Results for the First Quarter of Fiscal Year 2018 59
  • 6.24 Oct 25, 2017: GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER 60
  • 6.25 Oct 06, 2017: ResMed's European Patents Infringed by Fisher & Paykel in Germany 75
  • 6.26 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 76
  • 6.27 Sep 08, 2017: Dr. Davia Viellechner is the New Managing Director of PARI 77
  • 6.28 Sep 05, 2017: Electromed Announces Fiscal 2017 Fourth Quarter Financial Results 77
  • 6.29 Aug 31, 2017: TRACOE medical has already met the key requirements 79
  • 6.30 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy 79
  • 6.31 Aug 29, 2017: TRACOE medical with a positive mid-year balance for 2017 80
  • 6.32 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 80
  • 6.33 Aug 11, 2017: New Retail Director joins Drive DeVilbiss 83
  • 6.34 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 83
  • 6.35 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 85
  • 6.36 Aug 01, 2017: ResMed Announces Results for the Fourth Quarter of Fiscal Year 2017 87
  • 6.37 Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group 88
  • 6.38 Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK 94
  • 6.39 Jul 21, 2017: GSK announces Board and Committee changes 95
  • 6.40 Jul 10, 2017: Philips-sponsored study suggests positive airway pressure therapy could reduce COPD patient hospitalization 95
  • 6.41 Jul 01, 2017: TRACOE medical appoints commercial director Marcus Keidl to the Board 96
  • 6.42 Jun 19, 2017: GSK confirms start date for Luke Miels 97
  • 6.43 Jun 15, 2017: Trudell Medical International: Providing patient-focused solutions and reducing health system costs: our journey in the global fight against COPD 97
  • 6.44 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 99
  • 6.45 May 22, 2017: Fisher & Paykel Healthcare Launches New CPAP Device 101
  • 6.46 May 22, 2017: Fisher & Paykel Healthcare Reports Record Annual Result, Net Profit Up 18% 102
  • 6.47 May 17, 2017: Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel 103
  • 6.48 May 15, 2017: Electromed Announces Fiscal 2017 Third Quarter Financial Results 104
  • 6.49 May 09, 2017: Teijin Reports Revenue Of JPY741.3 Billion In Fiscal 2017 105
  • 6.50 May 04, 2017: Teleflex Reports First Quarter 2017 Results 105
  • 6.51 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 107
  • 6.52 Apr 27, 2017: ResMed Announces Results for the Third Quarter of Fiscal Year 2017 108
  • 6.53 Apr 26, 2017: GSK delivers another quarter of continued progress 109
  • 6.54 Apr 25, 2017: ResMed Unveils AirMini - the World's Smallest CPAP 112
  • 6.55 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 113
  • 6.56 Apr 11, 2017: Philips simplifies travel for sleep apnea patients with new compact and connected DreamStation Go sleep therapy device 114
  • 6.57 Mar 14, 2017: TRACOE medical Records Positive Results for the 2016 financial year 114
  • 6.58 Mar 08, 2017: Connecting Career Potential and Company Leadership Earned Cardinal Health Distinction from National Association for Female Executives 115
  • 6.59 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 116
  • 6.60 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 116
  • 6.61 Feb 22, 2017: The drug-free Aerobika device helps reduce the real-world impact of exacerbations in chronic obstructive pulmonary disease 118
  • 6.62 Feb 21, 2017: Electromed to Distribute Aerobika OPEP Device 119
  • 6.63 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 119
  • 6.64 Feb 17, 2017: Healthcare Industry Veteran, Jack Stoddard Joins NovaSom's Board of Directors 122
  • 6.65 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 122
  • 6.66 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 123
  • 6.67 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 142
  • 6.68 Feb 07, 2017: Electromed Announces Fiscal 2017 Second Quarter Financial Results 143

7 Appendix 146

  • 7.1 Methodology 146
  • 7.2 About GlobalData 149
  • 7.3 Contact Us 149
  • 7.4 Disclaimer 149
Back to Top
전화 문의
이용안내
 
BCC Research